Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
EFdA-TP tetrasodium inhibits HIV-1 RT with multiple mechanisms
is an orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities
7(4):672-7
30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14/h5-8
Ginsenoside Rk1 suppresses pro-inflammatory responses in lipopolysaccharide-stimulated RAW264
Indomethacin sodium hydrate - CAS# 74252-25-8 Catalog No.:M16485-C EFdA-TP tetrasodium inhibits HIV-1 RTIndomethacin sodium hydrate (Indometacin sodium hydrate) is a potent, blood brain permeable and nonselective inhibitor of COX1 and COX2, with IC50s of 18 nM and 26 nM for human COX 1 and COX 2, respectively, in CHO cells. Indomethacin sodium hydrate disrupts autophagic flux by disturbing the normal functioning of lysosomes. Product information CAS Number: 74252 25 8 Molecular Weight: 433. 82 Formula: C19H21ClNNaO7 Chemical Name: sodium 2 [1 (4
US$ 152.95
US$ 1888.00
US$ 110.99
US$ 1265.49
US$ 325.50